ArticleScience advances2024

Lymph-targeted high-density lipoprotein-mimetic nanovaccine for multi-antigenic personalized cancer immunotherapy.

Mingqi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.